Hematology NewsAllo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALLMarch 24, 2021TransplantALLLeukemia, Myelodysplasia, TransplantationImmunotherapy
Hematology NewsOmidubicel improves on umbilical cord blood transplantsMarch 22, 2021TransplantALLAMLCMLMyelodysplastic SyndromeB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsMaribavir seen as superior to other antivirals for CMV clearance post transplantMarch 4, 2021TransplantLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
Hematology NewsUsing engineered T cells reduced acute, chronic GVHDFebruary 23, 2021TransplantALLAMLB Cell LymphomaMyelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsTransplant-related mortality higher with CD34 selectionFebruary 22, 2021TransplantLeukemia, Myelodysplasia, TransplantationAML
Hematology NewsSteroid complications in GVHD common, boost costs of careFebruary 19, 2021TransplantALLMultiple MyelomaDLBCLB Cell LymphomaLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsChronic GVHD therapies offer hope for treating refractory diseaseFebruary 17, 2021TransplantLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMyelodysplastic SyndromeMultiple MyelomaALLAML
Oncology PracticeCOVID-19 vaccination in cancer patients: NCCN outlines prioritiesFebruary 1, 2021COVID-19 UpdatesTransplantPatient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary Cancer
Hematology NewsCaregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplantDecember 18, 2020Multiple MyelomaTransplantLymphoma & Plasma Cell Disorders
Hematology NewsExtended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Patient & Survivor CareCOVID-19 UpdatesLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantMultiple MyelomaMyelodysplastic Syndrome
Hematology News‘Practice changing’: Ruxolitinib as second-line in chronic GVHDDecember 8, 2020TransplantPatient & Survivor Care
Hematology NewsAllogeneic transplant leads to durable remissions in T-cell lymphomasDecember 6, 2020T Cell LymphomasTransplantLymphoma & Plasma Cell Disorders
Hematology NewsCan receiving HSCT care at home reduce the risk of GVHD and COVID-19?November 19, 2020Transplant
Hematology NewsPrevention of HMA failure a goal for high-risk MDS posttransplantNovember 13, 2020TransplantAMLMyelodysplastic SyndromeLeukemia, Myelodysplasia, Transplantation
